Arbutus Biopharma Corp. (ABUS)

4.46 -0.02 (-0.45%) USD  |  NASDAQ  |  Apr 06, 16:00
4.475 +0.02 (+0.34%) After-Hours: 20:00
More

Arbutus Biopharma Price to Book Value (3y Mean)

Price to Book Value (3y Mean) Chart

View Price to Book Value (3y Mean) for ABUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value (3y Mean) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to Book Value (3y Mean) Range, Past 5 Years

View Price to Book Value (3y Mean) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value (3y Mean) Benchmarks

View Price to Book Value (3y Mean) Benchmarks
Start Trial
Moderna, Inc. Upgrade
Merck & Co., Inc. Upgrade
Pfizer Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. --